Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reham Abdel-Wahab

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Gastroenterology|October 4, 2015
Reply: To PMID 25836985Manal M Hassan, Reham Abdel-Wahab, Donghui Li, et al.
International Review of Cell and Molecular Biology|July 7, 2025
The role of microbiome in CAR-T cell therapyReham Abdel-Wahab, Travis D Kerr, Daniel J McGrail, et al.
Oncotargets and Therapy|April 21, 2017
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?Mahmoud A Ali, Sahin Lacin, Reham Abdel-Wahab, et al.
Gastro Hep Advances|August 12, 2024
Treatment Patterns and Survival in Locally Advanced or Metastatic Biliary Tract Cancer Using SEER Medicare DataMark D Danese, Kabir Mody, Ramya Thota, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 13, 2016
Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkersSatoshi Takeuchi, Eric M Rohren, Reham Abdel-Wahab, et al.
Journal of Clinical Medicine|April 18, 2018
Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular CarcinomaAndrew Niekamp, Reham Abdel-Wahab, Joshua Kuban, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
Journal of Hepatocellular Carcinoma|August 11, 2016
Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaReham Abdel-Wahab, Samir Shehata, Manal M Hassan, et al.
Journal of Computer Assisted Tomography|May 15, 2019
Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib: A Pilot StudyDavid Fuentes, Kareem Ahmed, Jonathan S Lin, et al.
Oncotarget|September 23, 2016
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinomaAhmed Omar Kaseb, Manal Hassan, Sahin Lacin, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Gastroenterology|October 4, 2015
Reply: To PMID 25836985Manal M Hassan, Reham Abdel-Wahab, Donghui Li, et al.
International Review of Cell and Molecular Biology|July 7, 2025
The role of microbiome in CAR-T cell therapyReham Abdel-Wahab, Travis D Kerr, Daniel J McGrail, et al.
Oncotargets and Therapy|April 21, 2017
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?Mahmoud A Ali, Sahin Lacin, Reham Abdel-Wahab, et al.
Gastro Hep Advances|August 12, 2024
Treatment Patterns and Survival in Locally Advanced or Metastatic Biliary Tract Cancer Using SEER Medicare DataMark D Danese, Kabir Mody, Ramya Thota, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 13, 2016
Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkersSatoshi Takeuchi, Eric M Rohren, Reham Abdel-Wahab, et al.
Journal of Clinical Medicine|April 18, 2018
Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular CarcinomaAndrew Niekamp, Reham Abdel-Wahab, Joshua Kuban, et al.
Journal of Hematology & Oncology|May 31, 2018
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinomaReham Abdel-Wahab, Gauri R Varadhachary, Priya R Bhosale, et al.
Journal of Hepatocellular Carcinoma|August 11, 2016
Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaReham Abdel-Wahab, Samir Shehata, Manal M Hassan, et al.
Journal of Computer Assisted Tomography|May 15, 2019
Automated Volumetric Assessment of Hepatocellular Carcinoma Response to Sorafenib: A Pilot StudyDavid Fuentes, Kareem Ahmed, Jonathan S Lin, et al.
Oncotarget|September 23, 2016
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinomaAhmed Omar Kaseb, Manal Hassan, Sahin Lacin, et al.
Pageof 3